HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

CT-guided interstitial brachytherapy of primary and secondary lung malignancies: results of a prospective phase II trial.

AbstractBACKGROUND AND PURPOSE:
CT-guided interstitial brachytherapy of primary lung malignancies and pulmonary metastases represents a novel interventional technique, combining conventional high-dose-rate (HDR) iridium-192 ((192)Ir) brachytherapy with modern CT guidance for applicator positioning and computer-aided 3-D radiation treatment planning. The purpose of this study was to assess safety and efficacy of this technique.
PATIENTS AND METHODS:
30 patients with 83 primary or secondary lung malignancies were recruited in a prospective nonrandomized trial (Table 1). After catheter positioning under CT fluoroscopy, a spiral CT was acquired for treatment planning (Figure 1). All but two patients received a defined single dose (coverage > 99%) of at least 20 Gy from a (192)Ir source in HDR technique.
RESULTS:
Adverse effects were nausea (n = 3, 6%), minor (n = 6, 12%) and one major pneumothorax (2%). Post intervention, no changes of vital capacity and forced expiratory volume could be detected. The median follow-up period was 9 months (1-21 months) with a local tumor control of 91% at 12 months (Figure 2).
CONCLUSION:
CT-guided interstitial brachytherapy proved to be safe and effective for the treatment of primary and secondary lung malignancies.
AuthorsNils Peters, Gero Wieners, Maciej Pech, Susanne Hengst, Ricarda Rühl, Florian Streitparth, Enrique Lopez Hänninen, Roland Felix, Peter Wust, Jens Ricke
JournalStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] (Strahlenther Onkol) Vol. 184 Issue 6 Pg. 296-301 (Jun 2008) ISSN: 0179-7158 [Print] Germany
PMID18535804 (Publication Type: Clinical Trial, Phase II, Journal Article)
Chemical References
  • Radioisotopes
  • Iridium
Topics
  • Adult
  • Aged
  • Brachytherapy (methods)
  • Carcinoma, Non-Small-Cell Lung (radiotherapy)
  • Colorectal Neoplasms (radiotherapy)
  • Female
  • Fluoroscopy (methods)
  • Forced Expiratory Volume (radiation effects)
  • Humans
  • Image Processing, Computer-Assisted (methods)
  • Iridium (therapeutic use)
  • Lung Neoplasms (radiotherapy, secondary)
  • Male
  • Middle Aged
  • Nausea (etiology)
  • Pneumothorax (etiology)
  • Prospective Studies
  • Radioisotopes (therapeutic use)
  • Radiotherapy Dosage
  • Radiotherapy Planning, Computer-Assisted (methods)
  • Radiotherapy, Computer-Assisted (instrumentation)
  • Tomography, Spiral Computed (methods)
  • Vital Capacity (radiation effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: